MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT. Cell Cycle 8:2756-2768

Zhan Zhang(Third Affiliated Hospital of Zhengzhou University), Carla Grandori(Precision for Medicine (United States)), Janell M. Schelter, Ryan Walsh(Texas Neurology), Julja Burchard(Rosetta Stone (United States)), Joseph R. Marszalek(The University of Texas MD Anderson Cancer Center), Maki Imakura, Steven R. Bartz(Rosetta Stone (United States)), Peter S. Linsley(Rosetta Stone (United States)), Aaron N. Chang(Baylor University Medical Center), Hongyue Dai(Rosetta Stone (United States)), Michele A. Cleary(The Kids Research Institute Australia), Michael Carleton(Matrix Research (United States)), Xudong Dai, Robert L. Diaz, Hong Sun

Unknown

January 1, 2009

Cited by 3

|New England Journal of Medicine|2002|6.5k

|The Journal of Experimental Medicine|1991|1.7k

|Annual Review of Cell and Developmental Biology|2000|1.3k

|Cancer Discovery|2017|964

|Nature Genetics|1999|903

Related Papers